Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Sponsors
Pfizer
Conditions
Encephalitis, Tick-BorneEncephalitis, Tick-borne
Phase 2
FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years
CompletedNCT00161889
Start: 2002-02-28End: 2002-08-31Target: 615Updated: 2015-05-21
Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years
CompletedNCT00161746
Start: 1998-04-30End: 1999-06-30Updated: 2015-05-21
FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years
CompletedNCT00161850
Start: 2002-02-28End: 2002-08-31Target: 615Updated: 2015-05-21
Phase 3
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR
CompletedNCT00161824
Start: 2001-10-31End: 2002-01-31Target: 3800Updated: 2015-05-21
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years
CompletedNCT00161876
Start: 2002-05-31End: 2002-08-31Target: 3973Updated: 2015-05-21
Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
CompletedNCT00840801
Start: 2009-02-06End: 2010-05-20Updated: 2024-01-19
Phase 4
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
CompletedNCT00161954
Start: 2004-03-31End: 2004-05-31Updated: 2015-05-21
TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)
CompletedNCT00161967
Start: 2005-05-31End: 2008-11-30Target: 375Updated: 2015-05-21
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
CompletedNCT00503529
Start: 2007-07-31End: 2010-09-30Updated: 2015-05-21